Procurement Summary
Country: Japan
Summary: Keytruda Intravenous Infusion 100
Deadline: 20 Oct 2026
Posting Date: 18 Sep 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 149366402
Document Ref. No.:
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
33600000 - Pharmaceutical products
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Keytruda Intravenous Infusion 100
Classification: 0004 Medical & Pharmaceutical Products
Summay of Notice: ⑴ Official in charge of disbursement of the procuring entity : Hirotoshi Matsui, Director, National Hospital Organization Tokyo National Hospital
⑵ Classification of the products to be procured : 4
⑶ Nature and quantity of the products to be purchased : Keytruda Intravenous Infusion 100 ㎎
⑷ Fulfillment period : From November 1, 2026 through September 30, 2027
⑸ Delivery place : National Hospital Organization Tokyo National Hospital
⑹ Qualification for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall :
① not come under Article 5 of the Regulation concerning Contract for National Hospital Organization (NHO). Furthermore, minors, Person under Conservatorship or Person under Assistance that obtained the consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause ;
② not come under Article 6 of the Regulation concerning Contract for NHO ;
③ have Grade A, B, C or D in "Sales of products" for participating in tenders by Ministry of Health, Labour and Welfare (Single qualification for every ministry and agency) in Kanto-Koshinetsu Region ;
④ Be a person who has license of pharmaceutical sales business based on Pharmaceutical Affairs Law ;
⑤ Among the items shown in the "Pharmaceuticals Procurement List" issued separately, those who bid on narcotics are those who have a license for narcotics and drug shelf wholesale business based on the provision of Article 3 paragraph 1 of the Act on Control of Psychotropic Drugs about ;
⑺ Time-limit for tender : 5 : 00 P.M. October 20, 2026
⑻ Contact point for the notice : Masafumi Odajima, Director, Accounting Division, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka Kiyose-shi Tokyo 204-8585, Japan. TEL 042-491-2111 ext. 2250
Documents
Tender Notice